July 5, 2026
SOHO Insider Hem/Onc Library Myeloproliferative Neoplasms

MPN News

EHA 2026 Meetings / Conferences Myeloproliferative Neoplasms Primary Myelofibrosis Video Interviews

Early-phase trial data of INCA033989 shows durable responses in MF

taiwan flag
Myeloproliferative Neoplasms Polycythemia Vera

Taiwan regulatory body approves ropeginterferon alfa-2b-njft in ET

ASCO 2026 Meetings / Conferences Myeloproliferative Neoplasms Primary Myelofibrosis Video Interviews

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

ASCO 2026 Meetings / Conferences Myeloproliferative Neoplasms News

John Mascarenhas, MD, discusses the phase 3 SENTRY trial

EHA 2026 Meetings / Conferences Myeloproliferative Neoplasms Primary Myelofibrosis

Post-transplant molecular monitoring could prompt preemptive intervention in patients with myelofibrosis

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope
EHA 2026 Meetings / Conferences Myeloproliferative Neoplasms Primary Myelofibrosis

Novel germline JAK2 mutation linked to progression to MF in MPN

EHA 2026 Meetings / Conferences Myeloproliferative Neoplasms Primary Myelofibrosis

ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends 

Doctor holding an ipad
EHA 2026 Trending now Myeloproliferative Neoplasms Primary Myelofibrosis

Study identifies 4 clinically distinct myelofibrosis subtypes that have different survival prognoses

EHA 2026 ASCO 2026 Meetings / Conferences Myeloproliferative Neoplasms

Patients with myelofibrosis and anemia respond to antihemojuvelin drug

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda
Myeloproliferative Neoplasms Polycythemia Vera Primary Myelofibrosis News

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD